Loss of CD81 can affect the role of irisin in antagonizing obesity, insulin resistance, and adipose tissue inflammation, thus accelerating atherosclerosis, indicating the atheroprotective effect of irisin through integrin αVβ5 (13). The gene discussed is FNDC5; the disease is obesity disorder.